Skip to main content

1243 results

News

2023 Annual results

Annual sales: €529 million (stable at constant exchange rates) Essentials sales: €313m (+4.5% at constant exchange rates) Net income - Group share: €56m (10.5% of sales) EBITDA: €113m (21.3% of sales) Free Cash flow: €89 m Matthieu Frechin, Chairman and CEO of Vetoquinol, commented: “In 2023...
Publication

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights 02.2023 Consolidated financial statements 03.Strategy and outlook
Publication

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates) Essentials sales: €313m (+4.5% at constant exchange rates) Net income - Group share: €56m (10.5% of sales) EBITDA: €113m (21.3% of sales) Free cash-flow: €89m
Publication

Monthly information regarding the total number of voting rights – February 2024

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
Publication

Monthly information regarding the total number of voting rights – January 2024

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
Publication

Buyback programs – January 2024

Monthly communication regarding buyback programs
Publication

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)
Publication

Monthly information regarding the total number of voting rights – December 2023

As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
Publication

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.
Publication

Buyback programs - November 2023

Monthly communication regarding buyback programs